We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $786B
1-Year Est. Return 40.34%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+21.85%
1 Year Est. Return
+40.34%
3 Year Est. Return
+112.81%
5 Year Est. Return
+128.34%
10 Year Est. Return
+415.77%
AUM
$786B
AUM Growth
+$120B
Cap. Flow
-$10.6B
Cap. Flow %
-1.35%
Top 10 Hldgs %
13.38%
Holding
11,684
New
1,279
Increased
4,220
Reduced
4,368
Closed
1,272

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.15B
2
HONA
Honeywell Aerospace
HONA
+$611M
3
SPCX
SpaceX
SPCX
+$567M
4
AAPL icon
Apple
AAPL
+$511M
5
JBL icon
Jabil
JBL
+$463M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$1.49B
2
WDC icon
Western Digital
WDC
+$1.42B
3
LITE icon
Lumentum
LITE
+$951M
4
INTC icon
Intel
INTC
+$785M
5
IVV icon
iShares Core S&P 500 ETF
IVV
+$749M

Sector Composition

Rank Sector Weight
1 Miscellaneous 41.93%
2 Technology 18.61%
3 Financials 7.85%
4 Industrials 6.94%
5 Healthcare 5.8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMRA icon
6626
Neumora Therapeutics
NMRA
$140M
$244K ﹤0.01%
143,725
+84,141
+141% +$160K
AXIN
6627
Axiom Intelligence Acquisition Corp 1
AXIN
$282M
$244K ﹤0.01%
23,600
+21,699
+1,141% +$223K
OTLK icon
6628
Outlook Therapeutics
OTLK
$167M
$242K ﹤0.01%
152,215
+19,146
+14% +$11.9K
RTH icon
6629
VanEck Retail ETF
RTH
$239M
$242K ﹤0.01%
945
-435
-32% -$114K
MSTU
6630
T-Rex 2X Long MSTR Daily Target ETF
MSTU
$547M
$241K ﹤0.01%
14,903
-4,084
-22% -$224K
ENRD
6631
Einride AB American Depositary Shares
ENRD
$569M
$241K ﹤0.01%
+27,891
New +$245K
SPYI icon
6632
CALL
NEOS S&P 500 High Income ETF
SPYI
$11.9B
$240K ﹤0.01%
+4,512
New +$237K
CRNT icon
6633
Ceragon Networks
CRNT
$193M
$239K ﹤0.01%
92,302
+15,302
+20% +$40K
ALL icon
6634
PUT
Allstate
ALL
$63.8B
$238K ﹤0.01%
1,000
HOFT icon
6635
Hooker Furnishings Corp
HOFT
$140M
$238K ﹤0.01%
13,339
-17,936
-57% -$245K
KORE
6636
DELISTED
KORE Group Holdings
KORE
$237K ﹤0.01%
25,644
-118,937
-82% -$1.09M
NINE
6637
Nine Energy Service Inc
NINE
$141M
$236K ﹤0.01%
+18,167
New +$184K
SEAT icon
6638
Vivid Seats
SEAT
$46.9M
$236K ﹤0.01%
36,224
-9,558
-21% -$73.3K
GETY icon
6639
Getty Images
GETY
$94.3M
$236K ﹤0.01%
274,019
-22,248
-8% -$19.3K
MRDN
6640
Meridian Holdings Inc
MRDN
$177M
$235K ﹤0.01%
16,894
+2,427
+17% +$25.4K
IYLD icon
6641
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
$235K ﹤0.01%
10,612
+1,626
+18% +$36K
KLXE icon
6642
KLX Energy Services
KLXE
$32.1M
$235K ﹤0.01%
90,921
+76,556
+533% +$227K
NERV icon
6643
Minerva Neurosciences
NERV
$165M
$234K ﹤0.01%
42,208
-25,362
-38% -$138K
PZT icon
6644
Invesco New York AMT-Free Municipal Bond ETF
PZT
$137M
$234K ﹤0.01%
10,300
-23,975
-70% -$538K
JMSB icon
6645
John Marshall Bancorp
JMSB
$326M
$234K ﹤0.01%
10,735
-307
-3% -$6.51K
FRD icon
6646
Friedman Industries
FRD
$300M
$234K ﹤0.01%
7,272
-889
-11% -$21K
XYF
6647
X Financial
XYF
$180M
$233K ﹤0.01%
48,198
+4,141
+9% +$19.8K
WHWK
6648
Whitehawk Therapeutics
WHWK
$233M
$233K ﹤0.01%
50,841
+39,403
+344% +$164K
AVSF icon
6649
Avantis Short-Term Fixed Income ETF
AVSF
$652M
$233K ﹤0.01%
4,995
+4,932
+7,829% +$230K
USEA icon
6650
United Maritime
USEA
$29.5M
$232K ﹤0.01%
88,396
+8,507
+11% +$20K

Similar funds

UBS Group's Q2 2026 Portfolio in Review

As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

UBS Group's Q2 2026 filing shows 1,279 new, 4,220 increased, 4,368 reduced and 1,272 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.

By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.

  • UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
  • UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
  • UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
  • UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
  • UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
  • UBS Group opened 1,279 new positions and closed 1,272 in Q2 2026.
  • UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.